US-guided FICB After Hip Fracture: the Effect of the Local Anesthetic Volume on the Quality of Preoperative Analgesia

NCT ID: NCT04692857

Last Updated: 2021-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-02

Study Completion Date

2020-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

participants were randomly divided into three groups : group 30 , group 40 and group 50 . for all the three groups an ultrasound guided supra-inguinal fascia iliaca block had been performed.

for group 30 ,a volume of 30 ml of 0,2 % ropivacaine had been injected for group 40 ,a volume of 40 ml of 0,2 % ropivacaine had been injected for group 50 ,a volume of 50 ml of 0,2 % ropivacaine had been injected

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

participants were randomly divided into three groups : group 30 , group 40 and group 50 . for all the three groups an ultrasound guided supra-inguinal fascia iliaca block had been performed.

A linear ultrasound probe was placed in the sagittal plane to obtain an image of the superior iliac spine.the fascia iliaca and sartorious,iliopsoas,and oblique internal muscles were identified by sliding the probe medially. After identifiying the "bow-tie sign"formed by the muscle fascias , an 50 mm needle was introduced 1-2 cm inferior to the inguinal ligament.using an in-plane approch, the fascia iliaca was penetrated and hydrodissected , separating the fascia iliaca from the iliac muscle. in this created space a total volume of 30 ml, 40ml or 50ml of 0.2% ropivacaine was injected , respectively to group 30 ,group 40 and group 50 .

pain score at rest and with a straight leg raise of the affected limb to 15 degrees were assessed before and 30 minutes after block performance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group 30

participants received a supra inguinal fascia iliaca compartment block with 30 ml of 0.2% ropivacaine

Group Type EXPERIMENTAL

supra inguinal fascia iliaca block

Intervention Type PROCEDURE

injection of 30,40 or 50 ml of 0.2 ropivacaine .

group 40

participants received a supra inguinal fascia iliaca compartment block with 40 ml of 0.2% ropivacaine

Group Type EXPERIMENTAL

supra inguinal fascia iliaca block

Intervention Type PROCEDURE

injection of 30,40 or 50 ml of 0.2 ropivacaine .

group 50

participants received a supra inguinal fascia iliaca compartment block with 50 ml of 0.2% ropivacaine

Group Type EXPERIMENTAL

supra inguinal fascia iliaca block

Intervention Type PROCEDURE

injection of 30,40 or 50 ml of 0.2 ropivacaine .

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

supra inguinal fascia iliaca block

injection of 30,40 or 50 ml of 0.2 ropivacaine .

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients aged above 65 years , american society of anesthesiologists physical status I to III , and with body mass index (BMI) of 35 kg/m² or less , undergoing hip fracture surgical repair .

Exclusion Criteria

* inability or refusal to sign informed consent
* younger than 65 years
* BMI greater than 35 kg/m²
* presence of contraindications for regional nerve block or spinal anesthesia
* impaired cognition or dementia
* multiple fractures
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Tunis El Manar

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mechaal Benali

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

mechaal benali, PROFESSOR

Role: STUDY_CHAIR

university manar Tunis tunisia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mechaal Benali

Nabeul, Mrezga, Tunisia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Tunisia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UTEM VOL FIBSI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.